Estados financieros detallados de Agilon Health, Inc. (AGL): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Agilon Health, Inc. registró ingresos de $5.93B en el último ejercicio fiscal, con un CAGR de 5 años del 37.2%.
Márgenes de los últimos 12 meses: margen bruto 0.0%, margen operativo -4.5%, margen neto -4.2%.
Al precio actual de $89.66, AGL presenta beneficios negativos (P/E no significativo) y un ROE del -119.35%. La capitalización bursátil es de $1.5B.
Cuenta de Resultados (10 años)
| Año | 2019 | 2021 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Ingresos | $794.4M | $1.22B | $1.52B | $2.39B | $4.32B | $6.06B | $5.93B |
| Coste de Ventas | $765.9M | $1.12B | $1.46B | $2.28B | $4.25B | $6.06B | $6.12B |
| Beneficio Bruto | $28.5M | $94.2M | $65.7M | $111.4M | $69.7M | $4.8M | -$188.6M |
| I+D | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Generales y Administrativos | $122.8M | $137.3M | $427.5M | $207.8M | $285.8M | $268.9M | $238.5M |
| Gastos Operativos | $135.1M | $150.8M | $438.0M | $216.7M | $301.8M | $297.0M | $232.5M |
| Beneficio Operativo | -$106.6M | -$56.7M | -$372.2M | -$105.4M | -$232.1M | -$292.1M | -$421.1M |
| EBITDA | -$64.2M | -$40.1M | -$362.2M | -$72.4M | -$167.6M | -$218.2M | -$368.9M |
| Gastos por Intereses | $9.1M | $8.1M | $6.1M | $4.5M | $6.7M | $6.2M | $6.6M |
| Beneficio Antes de Impuestos | -$114.7M | -$62.3M | -$383.0M | -$90.7M | -$194.5M | -$248.8M | -$404.1M |
| Impuestos | -$232000 | $865000 | $886000 | $1.6M | $791000 | $1.5M | $1.3M |
| Beneficio Neto | -$282.6M | -$60.1M | -$406.5M | -$106.6M | -$262.6M | -$260.2M | -$405.3M |
| BPA | $-18.50 | $-4.00 | $-27.25 | $-6.50 | $-16.00 | $-15.75 | $-24.50 |
| BPA Diluido | $-18.50 | $-4.00 | $-27.25 | $-6.50 | $-16.00 | $-15.75 | $-24.50 |
| Acciones en Circulación (Diluidas) | $15.4M | $15.4M | $14.9M | $16.3M | $16.4M | $16.4M | $16.6M |
Cuenta de Resultados (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Ingresos | $1.44B | $1.57B | $1.42B | $1.49B |
| Beneficio Bruto | -$67.6M | -$97.6M | $58.2M | $107.1M |
| Beneficio Operativo | -$131.3M | -$155.8M | $10.1M | $11.8M |
| EBITDA | -$101.3M | -$178.9M | $34.9M | $11.2M |
| Beneficio Neto | -$110.2M | -$188.9M | $30.0M | $18.0M |
| BPA | $-6.75 | $-11.50 | $1.80 | $1.07 |
| BPA Diluido | $-6.75 | $-11.50 | $1.80 | $1.04 |
Balance (10 años)
| Año | 2019 | 2021 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Caja y Equivalentes | $123.6M | $106.8M | $1.05B | $465.3M | $114.3M | $193.9M | $173.7M |
| Inversiones a Corto | 0 | 0 | 0 | $411.9M | $380.8M | $211.7M | $111.4M |
| Cuentas por Cobrar | $93.3M | $144.6M | $293.4M | $492.4M | $942.5M | $1.02B | $673.8M |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $245.5M | $294.2M | $1.37B | $1.45B | $1.48B | $1.46B | $1.10B |
| Inmovilizado Material | $18.8M | $16.0M | $20.9M | $32.0M | $41.0M | $37.0M | $25.4M |
| Fondo de Comercio | $41.5M | $41.5M | $41.5M | $2.5M | $24.1M | $24.1M | 0 |
| Activos Intangibles | $71.1M | $60.5M | $55.4M | $18.4M | $63.8M | $72.8M | $65.7M |
| Activos Totales | $402.8M | $446.4M | $1.59B | $1.70B | $1.74B | $1.73B | $1.27B |
| Cuentas por Pagar | $188.3M | $260.1M | $348.7M | $478.2M | $968.1M | $1.15B | $1.06B |
| Deuda a Corto | $3.0M | $3.0M | $8.3M | $5.0M | $9.1M | $2.5M | $19.2M |
| Pasivos Corrientes | $199.6M | $266.8M | $357.0M | $535.1M | $977.2M | $1.15B | $1.08B |
| Deuda a Largo | $67.1M | $64.7M | $43.4M | $38.5M | $32.3M | $34.9M | $15.8M |
| Pasivos Totales | $634.8M | $731.1M | $494.7M | $656.9M | $1.08B | $1.26B | $1.14B |
| Reservas | -$491.1M | -$551.2M | -$957.7M | -$1.06B | -$1.33B | -$1.59B | -$1.98B |
| Patrimonio Neto | -$232.0M | -$284.7M | $1.09B | $1.04B | $661.8M | $471.0M | $126.7M |
| Deuda Total | $77.9M | $73.2M | $59.6M | $52.6M | $52.3M | $44.0M | $36.8M |
| Deuda Neta | -$45.7M | -$33.6M | -$995.2M | -$824.6M | -$442.8M | -$361.6M | -$248.3M |
| Capital Circulante | $45.9M | $27.4M | $1.01B | $916.2M | $502.9M | $305.8M | $20.2M |
Balance (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Caja y Equivalentes | $171.7M | $173.7M | $140.0M | $107.2M |
| Activos Totales | $1.60B | $1.27B | $1.50B | $1.59B |
| Pasivos Totales | $1.29B | $1.14B | $1.32B | $1.36B |
| Patrimonio Neto | $306.1M | $126.7M | $181.4M | $227.5M |
| Deuda Total | $37.1M | $36.8M | $33.4M | $33.4M |
Flujo de Caja (10 años)
| Año | 2019 | 2021 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Beneficio Neto | -$282.7M | -$60.1M | -$406.8M | -$106.9M | -$262.8M | -$260.1M | -$391.3M |
| Amortizaciones | $41.4M | $14.1M | $14.7M | $13.8M | $20.2M | $24.5M | $28.6M |
| Compensación en Acciones | $5.2M | $6.7M | $292.4M | $28.4M | $69.3M | $50.7M | $49.1M |
| Cambio en Capital Circulante | $33.2M | $6.5M | -$55.0M | -$59.4M | -$10.1M | $130.6M | $189.5M |
| Flujo de Caja Operativo | -$103.9M | -$53.2M | -$148.2M | -$130.8M | -$156.2M | -$57.8M | -$105.8M |
| Inversiones (CapEx) | -$3.9M | -$2.4M | -$13.4M | -$32.7M | -$30.8M | -$13.3M | -$13.2M |
| Adquisiciones | 0 | $26.2M | -$1.3M | $500000 | -$43.1M | 0 | 0 |
| Recompra de Acciones | 0 | -$6.7M | 0 | 0 | -$200.0M | 0 | -$3.0M |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$107.8M | -$55.6M | -$161.6M | -$163.5M | -$187.0M | -$71.0M | -$119.0M |
Flujo de Caja (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Flujo de Caja Operativo | -$18.2M | -$20.5M | $23.7M | -$57.3M |
| Inversiones (CapEx) | -$16.5M | -$17.0M | -$3.1M | -$3.4M |
| Flujo de Caja Libre | -$34.7M | -$37.6M | $20.6M | -$60.7M |
| Dividendos Pagados | 0 | 0 | 0 | 0 |
| Compensación en Acciones | $7.5M | $9.5M | $6.3M | $23.8M |
Crecimiento y Márgenes (10 años)
| Año | 2019 | 2021 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Crecimiento Ingresos (anual) | | +53.4% | +24.9% | +57.0% | +80.7% | +40.4% | -2.1% |
| Crecimiento Beneficio Neto (anual) | | +78.7% | -576.9% | +73.8% | -146.4% | +0.9% | -55.8% |
| Crecimiento BPA (anual) | | +78.4% | -581.2% | +76.1% | -146.2% | +1.6% | -55.6% |
| Cambio en Acciones (anual) | | +0.2% | -3.1% | +9.4% | +0.2% | +0.5% | +0.7% |
| Crecimiento FCF (anual) | | +48.4% | -190.9% | -1.2% | -14.4% | +62.0% | -67.5% |
| Margen Bruto | 3.6% | 7.7% | 4.3% | 4.7% | 1.6% | 0.1% | -3.2% |
| Margen Operativo | -13.4% | -4.7% | -24.5% | -4.4% | -5.4% | -4.8% | -7.1% |
| Margen EBITDA | -8.1% | -3.3% | -23.8% | -3.0% | -3.9% | -3.6% | -6.2% |
| Margen Neto | -35.6% | -4.9% | -26.7% | -4.5% | -6.1% | -4.3% | -6.8% |
| Margen FCF | -13.6% | -4.6% | -10.6% | -6.8% | -4.3% | -1.2% | -2.0% |
| Tasa Impositiva Efectiva | 0.2% | -1.4% | -0.2% | -1.8% | -0.4% | -0.6% | -0.3% |
Datos por Acción (10 años)
| Año | 2019 | 2021 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| FCF por Acción | $-7.02 | $-3.61 | $-10.83 | $-10.01 | $-11.43 | $-4.32 | $-7.19 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $15.4M | $15.4M | $14.9M | $16.3M | $16.4M | $16.4M | $16.6M |
Qué mirar en Salud / Farma
El pipeline de I+D es el activo invisible. Patentes que caducan = ingresos que evaporan. Mira innovación y flujo de caja.
- I+D / Ingresos — Indica inversión en pipeline futuro. Farma seria reinvierte 15-20%
- Crecimiento EPS 5y — Tras caducidad de patentes, ¿siguen creciendo?
- Margen bruto — Farma de marca >70%. Genéricos mucho más bajo — define el tipo de negocio
- FCF / Net Income — Calidad del beneficio — farma grande debería convertir >90%
- ROIC — Capital reinvertido con eficiencia — clave en farma por ciclos de I+D largos
- Deuda neta / EBITDA — Adquisiciones de farma generan mucha deuda — ojo al post-M&A
- P/E vs historial 10y propio — La mejor comparación es con su propia historia, no con competidores
Rentabilidad
| Rentabilidad sobre capital | -119.35% |
| Rentabilidad sobre capital invertido | -90.22% |
| Rentabilidad sobre activos | -15.78% |
| Margen bruto | 0.00% |
| Margen operativo | -4.48% |
| Margen neto | -4.24% |
Salud financiera
| Deuda / Patrimonio | 0.15 |
| Ratio corriente | 1.08 |
| Piotroski F-Score | 3 |
| Altman Z-Score | 1.56 |
Ratios Clave (10 años)
| Año | 2019 | 2021 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| P/E | -41.89 | -193.75 | -24.77 | -62.08 | -19.61 | -3.02 | -0.70 |
| P/VC | -51.31 | -41.90 | 9.22 | 6.33 | 7.75 | 1.66 | 2.25 |
| P/V | 14.99 | 9.79 | 6.62 | 2.76 | 1.19 | 0.13 | 0.05 |
| Margen Bruto | 3.6% | 7.7% | 4.3% | 4.7% | 1.6% | 0.1% | -3.2% |
| Margen Operativo | -13.4% | -4.7% | -24.5% | -4.4% | -5.4% | -4.8% | -7.1% |
| Margen Neto | -35.6% | -4.9% | -26.7% | -4.5% | -6.1% | -4.3% | -6.8% |